DME Fraud Statistics: Why Improper Payments and Takedown Dollars Are Different

DME fraud statistics start from Medicare’s payment-error estimate, which is not a fraud count: the Centers for Medicare & Medicaid Services’ fiscal 2025 payment-error table estimates $2.27 billion in improper payments for durable medical equipment, prosthetics, orthotics and supplies, a rate of 24.12%. Medicare can receive a false claim, schedule a payment and stop it before the supplier gets it. For a billing or compliance insider, the claim and the cash can tell very different stories.

The Office of Inspector General describes schemes involving undelivered equipment, unnecessary supplies, cheaper products billed under more expensive codes and fabricated medical-necessity records.

What the DME CERT Rate Measures

The DME CERT rate comes from Medicare’s Comprehensive Error Rate Testing program, which measures compliance with coverage, coding and billing requirements. Reviewers examine the documentation supporting sampled claims, including whether it supports the item billed. Missing documentation can put a payment into the error estimate.

Durable medical equipment, prosthetics, orthotics and supplies had the highest rate among the Medicare claim types in the fiscal 2025 table. Its claims window ran from July 1, 2023 through June 30, 2024.

The longer arc shows a substantial decline: the adjusted rate was 61.0% in 2011 and reached 21.4% in 2024 before rising in the latest report.

The fiscal 2025 estimate also carries a wide 95% confidence interval, from 16.7% to 31.6%.

CERT answers whether the sampled payment met Medicare’s requirements. A fraud investigation asks who created the order, what the supplier delivered and whether someone knowingly caused a false claim. Those questions require the people and business records behind the claim.

What Happens If DMEPOS Billing Is Improper?

Improper DMEPOS billing can lead to an overpayment finding and a demand to return the money.

In its October 2025 audit, the Office of Inspector General identified $22.7 million improperly paid for equipment and supplies provided during inpatient stays from 2018 through 2024. For the items in this audit, the inpatient facility should have furnished them itself or arranged for a supplier to do so. Medicare should not also have paid the supplier separately.

The Centers for Medicare & Medicaid Services changed its claims edits in January 2020, and improper payments fell substantially. They continued afterward. The audit recommended recovery of the identified overpayments and refunds of up to $5.9 million in deductibles and coinsurance that suppliers may have incorrectly collected from patients or on their behalf.

The Catheter Spike Hidden Inside an Orthotics Category

The catheter spending surge concentrated in A4352, the curved-tip catheter, and A4353, the catheter with insertion supplies. In its July 2024 proposed rule, the agency said spending on the selected catheter codes had remained below 0.1% of all Medicare fee-for-service spending in each year from 2016 through 2022, then rose to nearly 1% in 2023.

The product classification can hide that story. The Centers for Medicare & Medicaid Services’ public claims file groups those codes, along with the straight-tip catheter A4351, under DME-Orthotic Devices. An analyst who reads only the category total could describe a surge in braces when the underlying products are catheters. The code identifies what was billed more clearly than the category name.

Different parts of the program saw different parts of the problem. The proposed rule records that accountable care organizations alerted CMS to catheter billing affecting their expenditure totals. The agency’s urinary catheter case study says it identified a rise in early 2023 among fifteen suppliers that had recently changed ownership. Its investigation found that beneficiaries had not received the catheters, physicians had not ordered them and the supplies were unnecessary.

The expenditure reports showed the spending increase. The supplier cluster shared recent ownership changes. Beneficiaries supplied information that helped CMS withhold suspicious payments. Each added something a national total could not show.

When a Catheter Claim Says Paid

For a catheter claim under payment suspension, the decisive question is whether cash was disbursed. A submitted charge is what the supplier billed. An allowed amount is the amount recognized under the payment rules. Processing a claim and releasing its payment are separate steps, so the payment status belongs beside the paid field.

Operation Gold Rush makes the distinction concrete. In its June 30, 2025 announcement of the criminal indictment, the Justice Department said the indictment charged that an organization bought already-enrolled durable medical equipment suppliers, installed nominee owners and used stolen identities to submit false claims. The department’s national announcement separated the money this way:

The headline billing amount dwarfed the Medicare cash payment. The supplemental insurers supplied a separate stream of money. Combining the rows would erase the distinction that explains how the alleged scheme reached so far while Medicare stopped much of the payment.

A smaller criminal case shows the same accounting problem. The Justice Department’s July 2025 account of a Florida supplier owner’s criminal case described approximately $61.5 million in false claims and approximately $26.7 million paid. The owner had pleaded guilty. According to the court documents described in the announcement, he controlled five suppliers through nominee owners, concealed that control in enrollment and bank records, and knew a conspirator paid for patient referrals. Several supplier names concealed one controlling business.

DME CERT Zero-Dollar Catheter Errors and Gold Rush

DME CERT zero-dollar catheter errors explain why a payment suspension can leave a large billing scheme barely visible in the error rate. The Centers for Medicare & Medicaid Services’ fiscal 2025 supplemental report names Gold Rush in the note beneath its urological-supplies findings:

Those suspended claims were sampled in the error review and counted as errors, yet added nothing to the improper payment rate. An insider who can explain the orders and deliveries can show what that rate leaves out.

Why National Takedown Totals Outrun Durable Medical Equipment Statistics

National health care fraud takedowns combine different products, payers and alleged schemes. The 2025 announcement put intended losses across the action at more than $14.6 billion. It separately announced $34.3 million in civil settlements. The first figure described alleged exposure across the criminal cases. The second described agreements to pay in civil matters.

The product mix matters too. Earlier telemedicine actions combined equipment with cardiovascular and cancer genetic testing. A later brace allegation also included prescription skin creams. Assigning a mixed healthcare total to durable medical equipment gives the equipment business credit for claims involving other products.

Do DMEPOS Providers Bill Medicare?

DMEPOS suppliers bill Medicare, but the payer and claims channel change the population being counted. Fee-for-service supplier data covers Original Medicare. Medicare Advantage payments sit outside that population.

The Centers for Medicare & Medicaid Services’ National Health Expenditure Accounts put the broad all-payer durable medical equipment market at $86.4 billion in 2024, with Medicare accounting for $18.5 billion. That retail category includes eyeglasses and hearing aids, and its Medicare amount includes Medicare Advantage. It describes a wider market than Medicare fee-for-service supplier claims.

The distinction also matters inside an investigation. In its September 8, 2026 announcement, the Centers for Medicare & Medicaid Services identified eleven suppliers with more than $3.4 billion in suspected fraudulent billing during 2025 and 2026. Four had lost their Original Medicare enrollment and begun billing Medicare Advantage plans. The agency said all eleven had billed for deceased beneficiaries. One New Jersey supplier billed a Medicare Advantage plan for 38 separate encounters with dates of service after the beneficiaries had died.

The announcement also described a Florida supplier that submitted approximately $18.4 million in catheter claims over two consecutive days. CMS said payment suspensions prevented that money from reaching the supplier. A large claim total and a stopped payment can describe the same event.

What an Insider Adds to the Numbers

An insider can connect the claim to the transaction that produced it: the purchased lead, signed order, equipment code, delivery record and payment. That connection makes a billing pattern understandable.

A whistleblower complaint against Numotion supplies a more physical comparison. It alleged that equipment appearing as billed and paid still sat in storage:

The claim said delivered. The allegation pointed to the equipment itself. For a billing employee, warehouse manager or compliance reviewer, that is where a statistic becomes an account of what the company did.

The Claims You Can Explain

If you know why the orders, shipments and payments disagree, speak to one of our Whistleblower Experts about the supplier behind those numbers. We build your case around that knowledge, bring in durable medical equipment fraud whistleblower lawyers and stay beside you through the case. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.